NASDAQ · Healthcare · Biotechnology
Vertex Pharmaceuticals Incorporated
VRTX
Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). CEO Reshma Kewalramani · Market cap $129.5B.
$510.08
+6.83 · +1.36%
52w hi $560.2552w lo $402.58
Off 52w high 14.8%
48
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
2
0 buys · 2 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $552.53
Section 01
Recent Form 4 filings
4 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 06 | Reshma Kewalramani | CEO & President | Buy | 4,290 | $389.08 | +$1.67M | 61 |
| Aug 06 | Bruce I Sachs | Buy | 1,634 | $389.36 | +$636K | 49 | |
| Aug 06 | Reshma Kewalramani | CEO & President | Buy | 5,710 | $389.95 | +$2.23M | 64 |
| Aug 06 | Bruce I Sachs | Buy | 3,366 | $389.84 | +$1.31M | 55 |
Section 02
Recent STOCK Act disclosures
5 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Sep 07 | David Taylor | House · OH | Sell | $1,001 - $15,000 | $8K | 12 d | 48 |
| Sep 07 | David Taylor | House · OH | Sell | $1,001 - $15,000 | $8K | 13 d | 48 |
| May 13 | Ro Khanna | House · CA | Buy | $1,001 - $15,000 | $8K | 30 d | 35 |
| Jul 21 | Alan Armstrong | Senate | Buy | $1,001 - $15,000 | $8K | 116 d | 33 |
| Feb 03 | David Taylor | House · OH | Sell | $1,001 - $15,000 | $8K | 5 d | 51 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct